Alector Inc (NAS:ALEC)
$ 1.8 -0.030 (-1.65%) Market Cap: 199.84 Mil Enterprise Value: 27.88 Mil PE Ratio: 0 PB Ratio: 19.15 GF Score: 30/100

Alector Inc at Bank of America CNS Therapeutics Conference (Virtual) Transcript

Dec 08, 2025 / 07:25PM GMT
Release Date Price: $1.22
Operator

Ladies and gentlemen, the program is about to begin. At this time. It is my pleasure to turn the program over to your host, Alex Stranahan.

Alec Stranahan
Bofa Merrill Lynch Asset Holdings Inc - Analyst

All right, great. Thank you, operator, and thanks everyone for joining the session with Alector Therapeutics, part of our BFA 2025 CNS conference. My name is Alex Stranahan, I'm Senior Biotech Analyst, covering SMICA, and Alector at Bank of America.

And I have the pleasure of being joined today by, the electoral management team, including Arnon Rosenthal, co-founder, Chief Executive Officer, and Director; Giacomo Salvadore, Chief Medical Officer; and Neil Berkley, Chief Business Officer and Interim Chief Financial Officer. Thanks guys for being here.

Arnon Rosenthal
Alector Inc - Chief Executive Officer, Co-Founder, Director

Thank you for inviting us.

Questions & Answers

Alec Stranahan
Bofa Merrill Lynch Asset Holdings Inc - Analyst

Great. Well, let

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot